| Surgery Section - Cosmetic and Reconstructive
Surgery
| Topic: Cosmetic and Reconstructive Surgery |
Date of Origin: 01/1996 |
| Section: Surgery |
Policy No: 12 |
| Effective Date: 07/01/2011 |
|
| |
IMPORTANT REMINDER
Regence Medical Policies are developed to provide guidance for members and providers regarding
coverage in accordance with contract terms. Benefit determinations are based in all cases on
the applicable contract language. To the extent there may be any conflict between the Medical
Policy and contract language, the contract language takes precedence.
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that
are considered investigational or cosmetic. Providers may bill members for services or
procedures that are considered investigational or cosmetic. Providers are encouraged to inform
members before rendering such services that the members are likely to be financially responsible
for the cost of these services.
DESCRIPTION [1]
Cosmetic surgery is performed to reshape normal body
structures in order to improve appearance.
Reconstructive surgery is primarily performed to improve
or correct a functional impairment.
POLICY/CRITERIA
Many member contracts have very specific language
regarding covered reconstructive services and excluded
cosmetic procedures. Specific member contract
language has precedence over medical policy, and requests
for coverage of potentially cosmetic services should
be reviewed by applicable member contract language.
The following policy may be applied when member contract
language is not specific:
- If the intervention is intended
to treat a functional impairment and if no other
contract exclusions apply, it may be considered medically
necessary.
- If the intervention is not intended to treat a
functional impairment, the cause of the condition
must be determined, for example, accident/injury/trauma,
post-treatment, congenital anomaly, disease. If
the cause is included in the definition of reconstructive
services in the benefits contract language, then
the treatment may be covered.
The following flow chart may
be used as a guide to interpreting benefits language.
Is intervention intended to treat
a functional impairment?
|
----Yes--» |
Treatment
may be medically necessary. Check
for specific medical necessity criteria.* |
I
No
▼
|
|
Determine cause of condition (accident/injury/trauma,
post-treatment, congenital anomaly, disease) |
I
▼ |
Does benefit contract language include the cause
of the condition in the definition of reconstructive
services? |
----Yes--» |
Service may be covered |
I
No
▼ |
|
Service is considered cosmetic |
*See additional medical necessity criteria for the
following procedures:
Blepharoplasty and Brow Ptosis
Repair
Chemical Peels
Dermabrasion and Microdermabrasion
Laser Treatment for Port
Wine Stain
Mastectomy for Gynecomastia
Orthognathic
Surgery
Pectus Excavatum
Reconstructive
Breast Surgery/Mastopexy, and Management of Breast
Implants
Reduction
Mammaplasty
Varicose
Vein Treatment
Blepharoplasty and Brow Ptosis Repair Return
to Flow Chart
Description
Blepharoplasty is a surgical procedure performed on
the upper and/or lower eyelids to remove or repair
excess tissue that obstructs the field of vision. These
procedures may also be performed for cosmetic purposes
in the absence of visual field obstruction.
Functional visual impairment occurs when excess upper
eyelid tissue overhangs the upper eyelid margin and
results in significant superior visual field obstruction. Visual
field studies are used to determine the degree of obstruction. Visual
field studies should be measured both with and without
elevation of the excess tissue to determine the extent
of visual field defect at rest and the amount of improvement
that may be obtained from blepharoplasty.
Policy/Criteria
- In order to determine medical necessity the following
information will be requested:
- Visual fields, including physician
interpretation
- Documentation of clinically decreased vision
- Lateral and full face photographs
- Blepharoplasty for the following diagnoses may
be considered medically necessary for
an affected upper or lower lid without meeting visual
loss criteria:
- Trichiasis
- Ectropion
- Entropion
- In the absence of one of the conditions listed
above, unilateral or bilateral upper lid blepharoplasty
or levator resection may be considered medically
necessary for reconstructive purposes when
at least one eye meets all of the following criteria:
- Visual field is limited to 20 degrees or less
superiorly, or limited to 10 to 15 degrees or
less laterally, AND
- Frontal or lateral photographs demonstrate
visual field limitation consistent with the visual
field examination, AND
- Any related disease process, such as myasthenia
gravis or a thyroid condition is documented as
stable.
- Brow ptosis repair may be considered medically
necessary for reconstructive purposes
when at least one eye meets all of the criteria
for blepharoplasty above, and photographs demonstrate
the eyebrow is below the supraorbital rim.
- Blepharoplasty in anophthalmia may be considered medically
necessary when the upper eyelid position
interferes with the fit of a prosthesis in the
socket.
- Unilateral or bilateral upper lid blepharoplasty,
levator resection and brow ptosis repair is considered cosmetic when
the criteria in II, III, IV and V above are not met.
- Blepharoplasty of the lower lids for excessive
skin is considered cosmetic.
Chemical Peels [2] Return
to Flow Chart
Description
A chemical peel refers to a controlled removal of
varying layers of the epidermis and superficial dermis
with the use of a ‘wounding’ agent, such
as phenol or trichloroacetic acid (TCA). The most common
indication for chemical peeling is as a treatment of
photoaged skin, correcting pigmentation abnormalities,
solar elastosis, and wrinkles. However, chemical peeling
has also been used as a treatment for various stages
of acne and multiple actinic keratoses when treatment
of individual lesions is not feasible.
An epidermal peel may be used to remove fine, subtle
lines, soften the appearance of enlarged pores, improve
the skin texture and lighten hyper-pigmentary disorders.
Multiple epidermal peels (also referred to as chemical
exfoliation) may also be used in patients with active
acne.
Dermal peels may be used to treat deep wrinkling,
actinic damage, or actinic keratoses. Acne scarring
has also been treated with dermal peels.
Policy/Criteria
Epidermal Chemical Peels
- Epidermal chemical peels with 50 - 70% alpha hydroxy
acids may be considered medically necessary as
a treatment of active acne that has failed to respond
to a trial of topical and/or oral antibiotic acne
therapy.
- Epidermal chemical peels with 50 - 70% alpha hydroxy
acids is considered not medically
necessary as a first-line treatment of active
acne.
- Epidermal chemical peels for the treatment of photoaged
skin, wrinkles, or acne scarring are considered cosmetic.
Dermal Chemical Peels
- Dermal chemical peels may be considered medically
necessary to treat numerous (>10) actinic
keratoses or other premalignant skin lesions, when
treatment of the individual lesions becomes impractical.
- Dermal chemical peels are considered not medically
necessary to treat less than 10 actinic
keratoses or other premalignant skin lesions.
- Dermal chemical peels as treatments of end-stage
acne scarring are considered cosmetic.
Dermabrasion and Microdermabrasion Return
to Flow Chart
Description
Dermabrasion uses a rapidly moving brush to remove
skin and activate new skin growth. It is commonly
used for the treatment facial scars and wrinkles.
Microdermabrasion uses small microcrystals to abrade
the superficial epidermal layer of the skin; suction
is then used to remove any skin debris. Microdermabrasion
is often performed by estheticians for facial rejuvenation.
Policy/Criteria
- Dermabrasion to treat photoaged skin, wrinkles,
or acne scarring is considered cosmetic.
- Microdermabrasion for the treatment of any indication
is considered cosmetic.
Laser Treatment
of Port Wine Stains [3] Return
to Flow Chart
Description
Port wine stain (PWS) is a capillary malformation
that begins as a pale pink flat area (macular lesion)
in childhood and grows as the patient ages. Common
areas for PWS to appear are on the face over the areas
of the first and second trigeminal nerves and the eyes
or mouth. It is common to see a PWS overlying an arteriovenous,
arterial or venous malformation. The abnormal blood
vessels within the PWS become progressively more dilated
in size, which results in the lesion becoming dark
purple and elevated in some instances. Nodules and
hypertrophy may develop in the soft tissue underlying
the PWS. Nodules may continue to grow and can bleed
easily if traumatized. PWS persists into adult
life and is associated with systemic abnormalities
such as glaucoma.
Treatment of a PWS in its macular stage will prevent
the development of the hypertrophic component of the
lesion. Laser treatment of a PWS diminishes the existing
blood vessels making them smaller, fewer in number,
and less likely to progress in size.
Policy/Criteria
- Laser treatment may be considered medically
necessary for port wine stains.
- Destruction of cutaneous vascular lesions for removal
of telangiectasias (spider veins) is considered cosmetic.
Mastectomy for Gynecomastia Return
to Flow Chart
Description
Gynecomastia refers to the benign enlargement of the
male breast, either due to increased adipose tissue,
fibrous tissue, glandular tissue, or a combination
of all three. In some instances, adolescent gynecomastia
may be reported as tender or painful; however, this
pain is normally self-limiting or responds to analgesic
therapy. Typically no functional impairment is associated
with gynecomastia.
Policy/Criteria
Mastectomy as a treatment of gynecomastia is considered cosmetic.
Pectus Excavatum
Repair Return
to Flow Chart
Description
Pectus excavatum, commonly referred to as "funnel
chest," is a chest wall malformation in which
the sternum is depressed inward, causing midline narrowing
of the thoracic cavity. Although pectus excavatum may
be visually prominent, in most cases the loss of volume
is not significant and does not interfere with ventilation.
Pectus excavatum is occasionally associated with upper
or lower airway obstruction; however, when this condition
is successfully treated or resolves spontaneously,
the pectus deformity may lessen or disappear. Pectus
excavatum may also be associated with segmental bronchomalacia,
and in some patients, cardiac function may be adversely
affected. In many children, the heart is shifted leftward,
and in the rare patient, cardiac function may be adversely
affected.
Surgical correction of pectus excavatum is not physiologically
beneficial for the vast majority of patients; surgery
is most often sought due to psychological and cosmetic
concerns. However, for some patients with extreme deformity,
operative interventions may be indicated for functional
reasons.
Policy/Criteria
- Surgical repair of pectus excavatum may
be considered medically
necessary when at least two of the following
medical necessity criteria are met:
- Documented progression of the deformity
with associated symptoms.
- Pulmonary function studies indicate components
of restrictive airway disease.
- Haller Computerized Tomography (CT) scan index
greater than 3.25. This Haller CT index is the
ratio derived from a chest CT scan by dividing
the transverse diameter by the anterior-posterior
diameter.
- Cardiac evaluation (electrocardiogram [EKG],
chest CT, and/or echocardiogram) demonstrates
compression-caused mitral valve prolapse, abnormal
rhythm, conduction abnormalities, or significant
cardiac deformity.
- Surgical repair of pectus excavatum that does not
meet at least two of the criteria in I.A. – I.
D. above is considered not medically
necessary.
REFERENCES
- BlueCross BlueShield Association Medical Policy
Reference Manual "Reconstructive/Cosmetic Services." Policy
No. 10.01.09
- BlueCross BlueShield Association Medical Policy
Reference Manual "Chemical Peels." Policy
No. 8.01.16
- BlueCross BlueShield Association Medical Policy
Reference Manual "Laser Treatment of Port Wine
Stains." Policy No. 7.01.40
CROSS REFERENCES
Reconstructive
Breast Surgery/Management of Breast Implants,
Regence Medical Policy Manual, Surgery, Policy No.
40
Reduction
Mammoplasty, Regence Medical Policy Manual, Surgery,
Policy No. 60
Varicose
Vein Treatment, Regence Medical Policy Manual,
Surgery, Policy No. 104
Orthognathic
Surgery, Regence Medical Policy Manual, Surgery,
Policy No. 137
Autologous
Fat Grafting to the Breast and Adipose-derived Stem
Cells, Regence Medical Policy Manual, Surgery,
Policy No. 182
| CODES |
NUMBER |
DESCRIPTION |
| CPT |
11920 |
Tattooing, intradermal
introduction of insoluble opaque pigments to
correct color defects of skin, including micropigmentation;
6.0 sq cm or less |
| |
11921 |
Tattooing, intradermal
introduction of insoluble opaque pigments to
correct color defects of skin, including micropigmentation;
6.1 to 20.0 sq cm |
| |
11922 |
Tattooing, intradermal
introduction of insoluble opaque pigments to
correct color defects of skin, including micropigmentation;
each additional 20.0 sq cm, or part thereof |
| |
11950 |
Subcutaneous injection
of filling material (eg, collagen); 1 cc or less |
| |
11951 |
Subcutaneous injection
of filling material (eg, collagen); 1.1 to 5.0
cc |
| |
11952 |
Subcutaneous injection
of filling material (eg, collagen); 5.1 to 10.0
cc |
| |
11954 |
Subcutaneous injection
of filling material (eg, collagen); over 10.0
cc |
| |
15775 |
Punch graft for
hair transplant; 1 to 15 punch grafts |
| |
15776 |
Punch graft for
hair transplant; more than 15 punch grafts |
| |
15780 |
Dermabrasion;
total face (eg, for acne scarring, fine wrinkling,
rhytids, general keratosis) |
| |
15781 |
Dermabrasion;
segmental, face |
| |
15782 |
Dermabrasion;
regional, other than face |
| |
15783 |
Dermabrasion;
superficial, any site (eg, tattoo removal) |
| |
15786 |
Abrasion; single
lesion (eg, keratosis, scar) |
| |
15787 |
Abrasion; each
additional four lesions or less |
| |
15788 |
Chemical peel, facial; epidermal |
| |
15789 |
Chemical peel; facial; dermal |
| |
15792 |
Chemical peel; nonfacial; epidermal |
| |
15793 |
Chemical peel; nonfacial; dermal |
| |
15819 |
Cervicoplasty |
| |
15820 |
Blepharoplasty, lower eyelid |
| |
15821 |
Blepharoplasty with extensive
herniated fat pad |
| |
15822 |
Blepharoplasty, upper eyelid |
| |
15823 |
Blepharoplasty, upper eyelid;
with excessive skin weighting down lid |
| |
15824 |
Rhytidectomy; forehead |
| |
15825 |
Rhytidectomy; neck with platysmal
tightening (platysmal flap, P-flap) |
| |
15826 |
Rhytidectomy; glabellar frown
lines |
| |
15828 |
Rhytidectomy; cheek, chin and
neck |
| |
15829 |
Rhytidectomy; superficial musculoaponeurotic
system (SMAS) flap |
|
15830 |
Excision, excessive skin and subcutaneous tissue
(includes lipectomy); abdomen, infraumbilical panniculectomy |
| |
15832 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); thigh |
| |
15833 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); leg |
| |
15834 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); hip |
| |
15835 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); buttock |
| |
15836 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); arm |
| |
15837 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); forearm or hand |
| |
15838 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); submental fat pad |
| |
15839 |
Excision, excessive skin and subcutaneous
tissue (includes lipectomy); other area |
| |
15847 |
Excision, excessive skin and subcutaneous tissue
(includes lipectomy); abdomen (e.g., abdominoplasty)
(includes umbilical transposition and fascial plication |
| |
15876 |
Suction assisted lipectomy; head
and neck |
| |
15877 |
Suction assisted lipectomy; trunk |
| |
15878 |
Suction assisted lipectomy; upper
extremity |
| |
15879 |
Suction assisted lipectomy; lower
extremity |
| |
17106 |
Destruction of cutaneous vascular
proliferative lesions (e.g., laser technique);
less than 10 sq cm |
| |
17107 |
Destruction of cutaneous vascular
proliferative lesions (e.g., laser technique);
10.0 to 50.0 sq cm |
| |
17108 |
Destruction of cutaneous vascular
proliferative lesions (e.g., laser technique);
over 50 sq cm |
| |
17360 |
Chemical exfoliation for acne
(eg, acne paste, acid) |
| |
17380 |
Electrolysis epilation, each 30
minutes |
| |
17999 |
Unlisted procedure, skin, mucous
membrane and subcutaneous tissue |
| |
19300 |
Mastectomy for gynecomastia |
| |
19355 |
Correction of
inverted nipples |
| |
21137 |
Reduction forehead;
contouring only |
| |
21138 |
Reduction forehead;
contouring and application of contouring material
or bone graft (includes obtaining autograft) |
| |
21139 |
Reduction forehead;
contouring and setback of anterior frontal sinus
wall |
| |
21244 |
Reconstruction
of mandible, extraoral, with transosteal bone
plate (eg, mandibular staple bone plate) |
| |
21245 |
Reconstruction
of mandible, or maxilla, subperiosteal implant;
partial |
| |
21246 |
Reconstruction
of mandible, or maxilla, subperiosteal implant;
complete |
| |
21248 |
Reconstruction
of mandible or maxilla, endosteal implant (eg,
blade, cylinder); partial |
| |
21249 |
Reconstruction
of mandible or maxilla, endosteal implant (eg,
blade, cylinder); complete |
| |
21270 |
Malar augmentation,
prosthetic material |
| |
21280 |
Medial canthopexy |
| |
21282 |
Lateral canthopexy |
| |
21295 |
Reduction of masseter
muscle and bone (eg, for treatment of benign
masseteric hypertrophy); extraoral approach |
| |
21296 |
Reduction of masseter
muscle and bone (eg, for treatment of benign
masseteric hypertrophy); intraoral approach |
| |
21740 |
Reconstructive
repair of pectus excavatum or carinatum; open |
| |
21742 |
Reconstructive
repair of pectus excavatum or carinatum; minimally
invasive approach (Nuss procedure), without thoracoscopy |
| |
21743 |
Reconstructive
repair of pectus excavatum or carinatum; minimally
invasive approach (Nuss procedure), with thoracoscopy |
| |
26590 |
Repair macrodactylia,
each digit |
| |
30120 |
Excision or surgical
planing of skin of nose for rhinophyma |
| |
30400 |
Rhinoplasty, primary;
lateral and alar cartilages and/or elevation
of nasal tip |
| |
30410 |
Rhinoplasty, primary;
complete, external parts including bony pyramid,
lateral and alar cartilages, and/or elevation
of nasal tip |
| |
30420 |
Rhinoplasty, primary;
including major septal repair |
| |
30430 |
Rhinoplasty secondary;
minor revision (small amount of nasal tip work) |
| |
30435 |
Rhinoplasty secondary;
intermediate revision (bony work with osteotomies) |
| |
30450 |
Rhinoplasty secondary;
major revision (nasal tip work and osteotomies) |
| |
31830 |
Revision of tracheostomy
scar |
| |
41510 |
Suture of tongue
to lip for micrognathia (Douglas type procedure) |
| |
49250 |
Umbilectomy, omphalectomy,
excision of umbilicus |
| |
49560 |
Repair initial
incisional or ventral hernia, reducible |
| |
49565 |
Repair recurrent
incisional or ventral hernia, reducible |
| |
54360 |
Plastic operation
on penis to correct angulation |
| |
57291 |
Construction of
artificial vagina; without graft |
| |
57292 |
Construction of
artificial vagina; with graft |
| |
57295 |
Revision (including
removal) of prosthetic vaginal graft; vaginal
approach |
| |
57296 |
Revision (including
removal) of prosthetic vaginal graft; open abdominal
approach |
| |
57426 |
Revision (including removal)
of prosthetic vaginal graft, laparoscopic approach |
| |
67900 |
Repair or brow
ptosis (supraciliary, mid-forehead or coronal
approach) |
| |
67901 |
Repair of blepharoptosis;
frontalis muscle technique with suture or other
material (eg, banked fascia) |
| |
67902 |
Repair of blepharoptosis;
frontalis muscle technique with autologous fascial
sling (includes obtaining fascia) |
| |
67903 |
Repair of blepharoptosis;
(tarso) levator resection or advancement, internal
approach |
| |
67904 |
Repair of blepharoptosis; (tarso)
levator resection or advancement, external approach |
| |
67906 |
Repair of blepharoptosis; superior
rectus technique with fascial sling (includes
obtaining fascia) |
| |
67908 |
Repair of blepharoptosis; conjunctivo-tarso-Muller’s
muscle-levator resection (e.g., Fasanella-Servat
type) |
| |
67909 |
Reconstruction of overcorrection
of ptosis |
| |
67911 |
Correction of lid retraction |
|
67916 |
Repair of ectropion; excision
tarsal wedge |
|
67917 |
Repair of ectropion; extensive
(eg, tarsal strip operations) |
|
67923 |
Repair of entropion; excision
tarsal wedge |
|
67924 |
Repair of entropion; extensive
(eg, tarsal strip or capsulopalpebral fascia
repairs operations) |
| |
67950 |
Canthoplasty (reconstruction
of canthus) |
| |
69090 |
Ear piercing |
| |
69300 |
Otoplasty, protruding
ear, with or without size reduction |
| HCPCS |
G0429 |
Dermal filler injection(s) for
the treatment of facial lipodystrophy syndrome
(LDS) (e.g., as a result of highly active antiretroviral
therapy) |
| |
Q2026 |
Injection, Radiesse, 0.1 ML |
| |
Q2027 |
Injection, Sculptra, 0.1 ML |
Surgery Section Table of Contents 

|